Image Results

Cytogen Patents Pages on BioPortfolio:

BioPortfolio - Cytogen
Cytogen Patents: US Patent No. Title. 7279548, Identification and isolation of novel polypeptides having WW domains and methods of using same ...
http://www.bioportfolio.com/biocorporate/3174-Cytogen.html...

BioPortfolio - Cytogen - Profile
7 Jul 2009 ... View the current Cytogen Page on BioPortfolio.com .... information resources: publications, clinical trials, patents and global news. ...
http://www.bioportfolio.com/biocorporate/3174-Cytogen.pdf...

BioPortfolio - Mouth
US Patent No. Title. 7598058, Nucleic acids encoding IL13 mutants ... Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and ...
http://www.bioportfolio.com/indepth/Mouth.html...

BioPortfolio Client Press Releases Site Map
... Dowpharma and Cytogen Agree to Develop PSMA Antibody for Treatment of ... Oxford Biomedica Receives Notice Of Allowance For Us Lentivector® Patent ...
http://www.bioportfolio.com/news/site_map.htm...

Results from other life science and pharmaceutical sites:

Print 5162504FOIA (3 pages)
Washington, D.C. 20231. W. Scott McNees Re: Patent Term Extension. Cytogen Corporation Application for. 600 College Road East U.S. Patent No. 5162504 ...
http://www.uspto.gov/web/offices/com/sol/foia/comm/pte/51625...

{1} And {2} Release: Newly Published Study Shows COMBIDEX(R) Aids ...
Cytogen has exclusive rights in the United States to market COMBIDEX. ... 87) uncertainties relating to patents and proprietary rights and other risks ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1780102...

IsraeliCV
International patent application filed November 1993. Patents granted July 23, 1996. Licensed in part to Cytogen Corporation, Princeton, N.J. ...
http://www.siuh.edu/urologic/israelicv.html...

prostascint (Capromab Pendetide) [CYTOGEN Corporation] - DailyMed ...
... or in part by at least the following US patents: #4671958, #4741900, and # 5162504. ... ProstaScint®is a registered trademark of CYTOGEN Corporation ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3681...

Terms Extended Under 35 U.S.C. 156 - OG Date: 22 September 1998
U.S. Patent No. 5162504; Granted November 10, 1992, to Julius S. Horoszewicz; Owner of Record: Cytogen Corporation; Title: Monoclonal Antibodies to a New ...
http://www.uspto.gov/go/og/1998/week38/patusc1.htm...

WISE::Staff:: Michael J. Manyak, MD Bio
Cytogen Corporation 1991- Schering-Plough, Inc. 1992-96 .... Determining Invasiveness of Prostatic Adenocarcinoma, US Patent # 5830640 ...
http://www.gwumc.edu/wise/manyakbio.htm...

Adegbola AA, Gonzales MI, Chess A, LaSalle JM, Cox GF. 2009. A ...
Clinical Research. Research Pipeline · Patents and Literature ..... Canc Genet & Cytogen 156:186-187. Waller K, Chaithongwongwatthana S, Yamasmit W, ...
http://www.genzyme.com/research/patents/literature_genetics....

Martha Stampfer, Ph.D. Senior Scientist Radcliffe College, Harvard ...
Cytogen 16:49-64, 1985. Bartley, J.C., and Stampfer, M.R., Factors Influencing ..... Epithelial Cells, U.S. Patent No. 4423145, issued December 27, 1983. ...
http://www.lbl.gov/lsd/People_&_Organization/Scientific_Staf...

Bagley RG, Weber W, Rouleau C, Yao M, Honma N, Kataoka S, Ishida I ...
Clinical Research. Research Pipeline · Patents and Literature ..... Canc Genet & Cytogen 157:70-73. Shah R, Rowland B, Richkind K, Mowery-Rushton P, ...
http://www.genzyme.com/research/patents/literature_cancer.as...

Reportlinker Adds World Cancer Therapies Market Report
Patent Expiries of Branded Drugs to Trigger Generic Competition II-1 .... FDA Approves IND Indication for CYT-500 of Cytogen II-60 ...
http://www.prnewswire.com/news-releases/reportlinker-adds-wo...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.